Bisoprolol transdermal patch improves orthostatic hypotension in patients with chronic heart failure and hypertension

β blockers (BBs) play an important role in heart failure (HF) treatment. However, orthostatic hypotension (OH) is sometimes caused by BBs. The bisoprolol transdermal patch works more slowly and is long acting compared with the bisoprolol fumarate tablet. The risk of OH may be reduced by using the bi...

Full description

Bibliographic Details
Published in:	Clinical and Experimental Hypertension
Main Authors:	Shunsuke Kiuchi, Shinji Hisatake, Takayuki Kabuki, Takashi Oka, Shintaro Dobashi, Takahiro Fujii, Takahide Sano, Takanori Ikeda
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2020-08-01
Subjects:	bisoprolol transdermal patch bisoprolol fumarate tablet chronic heart failure blood pressure variability orthostatic hypotension
Online Access:	http://dx.doi.org/10.1080/10641963.2020.1723616

Similar Items

Design and Evaluation of Bisoprolol Fumarate Transdermal Film: A Promising Approach for Cardiovascular Therapy
by: H. N. Shivakumar, et al.
Published: (2025-01-01)

Advances in quality control through the development of a more sustainable and eco-friendly direct spectrophotometric method than pharmacopoeial methods for the determination of bisoprolol fumarate
by: Safwan Ashour
Published: (2025-07-01)

THE USE OF BETA-BLOCKER BISOPROLOL FOR THE PREVENTION OF HIGH BLOOD PRESSURE IN WOMEN WITH IDIOPATHIC ARTERIAL HYPOTENSION
by: M. P. SAVENKOV, et al.
Published: (2016-12-01)

Development and Validation of a Novel Analytical Method (Ion Pair HPLC) For Separating and Determining Bisoprolol Fumarate and Carvedilol in Pure and Their Pharmaceutical Forms.
by: Duaa Alhuseen, et al.
Published: (2024-06-01)

Application of Hydrophilic Polymers to the Preparation of Prolonged-Release Minitablets with Bromhexine Hydrochloride and Bisoprolol Fumarate
by: Agata Grzejdziak, et al.
Published: (2024-08-01)

EXPERIENCE IN THE USE OF BISOPROLOL IN THE TREATMENT OF OUTPATIENT HYPERTENSIVE PATIENTS AFTER STROKE
by: I. I. Esenova, et al.
Published: (2015-09-01)

Orthostatic hypotension: An overlooked but clinically decisive entity
by: Gunja Jain, et al.
Published: (2022-01-01)

Stability indicating eco-friendly HPLC method development and validation for the estimation of bisoprolol fumarate and telmisartan
by: Hitanshi Darji, et al.
Published: (2025-01-01)

Study of forced degradation of amlodipine besylate and bisoprolol fumarate by application of hydrophilic interaction liquid chromatography
by: Kasagić-Vujanović Irena, et al.
Published: (2014-01-01)

THE BISOPROLOL — A HIGH SELECTIVE BETA-BLOCKER ACCORDING TO EVIDENCE BASED MEDICINE
by: Yu. V. Lukina, et al.
Published: (2016-01-01)

Beta-adrenoblocker in heart failure: bisoprolol role
by: Yu. V. Lukina, et al.
Published: (1970-01-01)

BISOPROLOL AND METFORMIN IN PATIENTS WITH ARTERIAL HYPERTENSION AND METABOLIC SYNDROME
by: V. A. Nevzorova, et al.
Published: (2015-12-01)

Comparative effect of bisoprolol and losartan in the treatment of essential hypertension
by: Goran Kekovic, et al.
Published: (2012-01-01)

Orthostatic hypotension. Part 2: diagnosis and treatment
by: G. A. Golovina, et al.
Published: (2020-09-01)

Managing postoperative atrial fibrillation after open-heart surgery using transdermal β1 blockers
by: Kenji Yamamoto, et al.
Published: (2023-04-01)

Bioequivalence of bisoprolol, coated tablets 10 mg JSC «Chimpharm» Republic of Kazakhstan
by: Y. M. Budach, et al.
Published: (2013-04-01)

ORTHOSTATIC HYPOTENSION. PART 1: DEFINITION, CLASSIFICATION, NATURAL HISTORY
by: G. A. Golovina, et al.
Published: (2019-04-01)

ORTHOSTATIC HYPOTENSION. PART 1: DEFINITION, CLASSIFICATION, NATURAL HISTORY
by: G. A. Golovina, et al.
Published: (2019-04-01)

Monitoring Serum Bisoprolol Concentrations in Patients With Heart Failure With Reduced Ejection Fraction: Results of a Pilot Study From Routine Health Care
by: Ivana Kacirova, et al.
Published: (2025-06-01)

Efeito do bisoprolol sobre a função cardíaca e o exercício em pacientes com insuficiência cardíaca Effects of bisoprolol on cardiac function and exercise in patients with heart failure
by: Victor Sarli Issa, et al.
Published: (2007-03-01)

Acute Intoxication by Bisoprolol and Drowning: Toxicological Analysis in Complex Suicides
by: Anna Carfora, et al.
Published: (2023-01-01)

History of combined protection: 25 years of using the fixed-dose combination of amlodipine and bisoprolol in clinical practice
by: Sergey R. Gilyarevsky, et al.
Published: (2022-03-01)

CARDIO-SELECTIVE Β-BLOCKER BISOPROLOL IN THE MANAGEMENT OF CORONARY HEART DISEASE
by: V. P. Lupanov
Published: (2011-06-01)

The bisoprolol efficiency predictors in patients with stable angina after myocardial infarction
by: O. V. Zamakhina, et al.
Published: (2019-04-01)

EFFECTS OF AMLODIPINE AND BISOPROLOL ON CAROTID AND VERTEBRAL BLOOD FLOW IN PATIENTS WITH ARTERIAL HYPERTENSION
by: E. D. Golovanova, et al.
Published: (2016-01-01)

Potential application of bisoprolol derivative compounds as antihypertensive drugs: synthesis and in silico study
by: Ni Putu Sani Oktaviani, et al.
Published: (2023-12-01)

Bisoprolol effectiveness in arterial hypertension and coronary heart disease
by: O. D. Ostroumova, et al.
Published: (1970-01-01)

COMPARATIVE EFFICACY OF AMIODARONE AND BISOPROLOL IN TREATMENT OF VENTRICULAR PREMATURE BEATS IN PATIENTS WITH METABOLIC SYNDROME
by: V. M. Provotorov, et al.
Published: (2016-01-01)

Anti-ischemic and antiarrhythmic effectiveness of long-term bisoprolol therapy in patients with myocardial infarction
by: R. T. Shukurov, et al.
Published: (2011-04-01)

Orthostatic Hypotension Management in Patients with Traumatic Cervical Myelopathy
by: Fedor A. Bushkov, et al.
Published: (2022-02-01)

BISOPROLOL EFFICACY IN PATIENTS WITH ARTERIAL HYPERTENSION ASSOCIATED WITH CARDIOPULMONARY DISEASES
by: G. N. Gorokchovskaya, et al.
Published: (2016-01-01)

Bioequivalence of China- and Germany-manufactured bisoprolol (Concor®) tablets in fasted and fed healthy Chinese participants: a randomized, open-label, two-way, crossover study
by: Hang Yin, et al.
Published: (2025-03-01)

Knowledge of Orthostatic Hypotension among Doctors Working at a Tertiary Care Hospital in Sri Lanka
by: Shehan Silva, et al.
Published: (2025-01-01)

COMPARATIVE EVALUATION OF THE EFFECT OF COMBINATION THERAPY WITH BISOPROLOL BISOPROLOL MONOTHERAPY AND IVABRADINE ON LEFT VENTRICULAR SYSTOLIC FUNCTION, CENTRAL HEMODYNAMICS IN PATIENTS WITH CHRONIC ISCHEMIC HEART DISEASE, WITH MODERATELY REDUCED EJECTION
by: /. Katsytadze
Published: (2015-09-01)

REGULATORY-ADAPTIVE STATE IN EVALUATION OF BISOPROLOL AND NEBIVOLOL THERAPY EFFECTIVENESS FOR VENTRICULAR ARRHYTHMIA
by: I. Z. Shubitidze, et al.
Published: (2016-12-01)

REGULATORY-ADAPTIVE STATUS IN COMPARISON OF BISOPROLOL AND SOTALOL EFFICACY IN VENTRICULAR RHYTHM DISORDERS
by: V. G. Tregubov, et al.
Published: (2018-03-01)

Orthostatic hypotension: definition, classification and evaluation
by: Irma Tzur, et al.
Published: (2019-05-01)

Lhermitte-Duclos Disease with Orthostatic Hypotension
by: Nesrin Helvacı Yılmaz, et al.
Published: (2016-09-01)

Aggregation of Gold Nanoparticles for Spectrophotometric Determination of Bisoprolol Hemifumarate, Buspirone HCl and Doxazosin Mesylate
by: Magda Mohamed Ayad, et al.
Published: (2019-03-01)

Three spectrophotometric quantitative analysis of bisoprolol fumarate and telmisartan in fixed-dose combination utilizing ratio spectra manipulation methods
by: Osama I. Abdel Sattar, et al.
Published: (2024-10-01)